ArticleFrontiers in oncology2026
Mesenteric neurofibromatosis complicated by acute appendicitis: case report and review of the literature.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An unexpected challenge: intra-abdominal neurofibromatosis during biliary reconstruction: a case report.Annals of medicine and surgery (2012) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mesenteric neurofibromatosis, a rare complication of neurofibromatosis type 1 (NF-1), comprises benign plexiform neurofibromas with recognized potential for malignant transformation. These lesions are frequently asymptomatic and diagnostically elusive, mimicking more common gastrointestinal pathologies. We report the incidental intraoperative discovery of mesenteric neurofibromatosis during surgery for acute appendicitis in an NF-1 patient, a presentation scarcely documented previously. This case highlights the occult nature of gastrointestinal involvement in NF-1 and underscores the critical need for systematic imaging surveillance to enable early detection and intervention. Case presentation: A 17-year-old female presented with a one-week history of right lower quadrant pain. An abdominal CT scan was consistent with acute appendicitis. Physical examination revealed numerous café-au-lait macules, and a significant family history confirmed a concurrent diagnosis of neurofibromatosis type 1 (NF-1). During a scheduled laparoscopic appendectomy, diffuse nodular lesions were incidentally discovered throughout the small bowel mesentery. Histopathological analysis of a biopsied lesion confirmed mesenteric neurofibromatosis. The patient had an uncomplicated postoperative recovery and remained asymptomatic at three-month follow-up. Conclusion: These findings underscore the necessity for imaging-based screening to detect gastrointestinal lesions early in patients with neurofibromatosis type 1 (NF-1). Heightened awareness of the potential presence of mesenteric neurofibromatosis, a rare manifestation of NF-1, is particularly warranted in the surgical setting when abdominal procedures are indicated for these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.